25 related articles for article (PubMed ID: 19058212)
1. Non-Hodgkin's lymphoma in patients with glioma treated with temozolomide.
Neyns B; Cordera S; Joosens E; Pouratian N
J Clin Oncol; 2008 Sep; 26(27):4518-9. PubMed ID: 18802168
[No Abstract] [Full Text] [Related]
2. Non-Hodgkin lymphoma following temozolomide.
Sharma A; Gupta D; Mohanti BK; Thulkar S; Dwary A; Goyal S; Muzumder S; Das P
Pediatr Blood Cancer; 2009 Oct; 53(4):661-2. PubMed ID: 19533661
[TBL] [Abstract][Full Text] [Related]
3. Mutagenic potential of temozolomide in bone marrow cells in vivo.
Geiger H; Schleimer D; Nattamai KJ; Dannenmann SR; Davies SM; Weiss BD
Blood; 2006 Apr; 107(7):3010-1. PubMed ID: 16554488
[No Abstract] [Full Text] [Related]
4. Bone marrow transplantation for severe aplastic anemia secondary to temozolomide.
Morris EB; Kasow K; Reiss U; Ellison D; Broniscer A
J Neurooncol; 2009 Jan; 91(2):237-9. PubMed ID: 18818880
[TBL] [Abstract][Full Text] [Related]
5. Possible leukemogenic potential of temozolomide.
Weiss B; Geiger H; Davies SM
Pediatr Blood Cancer; 2009 Apr; 52(4):553. PubMed ID: 19058212
[No Abstract] [Full Text] [Related]
6. Temozolomide may induce therapy-related acute lymphoblastic leukaemia.
Ogura M; Todo T; Tanaka M; Nannya Y; Ichikawa M; Nakamura F; Kurokawa M
Br J Haematol; 2011 Sep; 154(5):663-5. PubMed ID: 21518332
[No Abstract] [Full Text] [Related]
7. [Treatment of glioma with temozolomide].
Nishikawa R
Brain Nerve; 2009 Jul; 61(7):849-54. PubMed ID: 19618863
[TBL] [Abstract][Full Text] [Related]
8. Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide.
Grant LM; Kleiner DE; Conjeevaram HS; Vuppalanchi R; Lee WM
Dig Dis Sci; 2013 May; 58(5):1415-21. PubMed ID: 23212393
[TBL] [Abstract][Full Text] [Related]
9. Temozolomide in malignant gliomas: current use and future targets.
Villano JL; Seery TE; Bressler LR
Cancer Chemother Pharmacol; 2009 Sep; 64(4):647-55. PubMed ID: 19543728
[TBL] [Abstract][Full Text] [Related]
10. Emergence of cytomegalovirus disease in patients receiving temozolomide: report of two cases and literature review.
Meije Y; Lizasoain M; García-Reyne A; Martínez P; Rodríguez V; López-Medrano F; Juan RS; Lalueza A; Aguado JM
Clin Infect Dis; 2010 Jun; 50(12):e73-6. PubMed ID: 20455691
[TBL] [Abstract][Full Text] [Related]
11. Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: case study and review of the literature.
Noronha V; Berliner N; Ballen KK; Lacy J; Kracher J; Baehring J; Henson JW
Neuro Oncol; 2006 Jul; 8(3):280-3. PubMed ID: 16728498
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
